3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
41
Non-Muscle Invasive Bladder Neoplasms
25
Colorectal Neoplasms
20
Anus Neoplasms
17
Carcinoma, Transitional Cell
15
Neoplasm Metastasis
12
Carcinoma, Hepatocellular
10
Appendiceal Neoplasms
10
Stomach Neoplasms
9
Peritoneal Neoplasms
9
Pancreatic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Neoplasms
6
Lung Neoplasms
6
Colonic Neoplasms
6
Rectal Neoplasms
5
Liver Neoplasms
5
Sarcoma
4
Anal Canal Carcinoma
4
Urologic Neoplasms
3
Urologic Diseases
3
Urinary Bladder Diseases
3
Pseudomyxoma Peritonei
3
Mesothelioma, Malignant
3
Gastrointestinal Neoplasms
3
Carcinoma in Situ
3
Carcinoma
3
Breast Neoplasms
3
Urogenital Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Interventions
Cyclophosphamide
151
Dexamethasone
140
Rituximab
83
fludarabine
78
Cytarabine
69
Lenalidomide
68
Bortezomib
63
fludarabine phosphate
62
Gemcitabine
62
venetoclax
54
Etoposide
53
pembrolizumab
52
pomalidomide
48
Paclitaxel
48
Cisplatin
47
Carboplatin
47
Peripheral Blood Stem Cell Transplantation
46
Filgrastim
40
Radiotherapy
39
Calcium Dobesilate
36
Busulfan
36
Methotrexate
34
Melphalan
34
Bevacizumab
33
carfilzomib
32
Cyclosporine
32
Azacitidine
32
Mycophenolic Acid
29
Vincristine
28
Temozolomide
28
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Recurrence
×
Mitomycin
×
Clear all
NCT06781879
2025-10-03
COBRA-NMIBC
Aarhus University Hospital
Phase 4
Recruiting
272 enrolled